Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors
- PMID: 1566048
- DOI: 10.1126/science.1566048
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors
Abstract
Colorectal (CR) tumors are usually curable if detected before metastasis. Because genetic alterations are associated with the development of these tumors, mutant genes may be found in the stool of individuals with CR neoplasms. The stools of nine patients whose tumors contained mutations of K-ras were analyzed. In eight of the nine cases, the ras mutations were detectable in DNA purified from the stool. These patients included those with benign and malignant neoplasms from proximal and distal colonic epithelium. Thus, colorectal tumors can be detected by a noninvasive method based on the molecular pathogenesis of the disease.
Similar articles
-
Detecting colorectal cancer in stool with the use of multiple genetic targets.J Natl Cancer Inst. 2001 Jun 6;93(11):858-65. doi: 10.1093/jnci/93.11.858. J Natl Cancer Inst. 2001. PMID: 11390535
-
Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.Int J Oncol. 2002 Jun;20(6):1263-8. Int J Oncol. 2002. PMID: 12012008
-
Prognostic significance of K-ras mutations in colorectal carcinoma.Gastroenterology. 1993 Apr;104(4):1044-8. doi: 10.1016/0016-5085(93)90272-e. Gastroenterology. 1993. PMID: 8462792
-
[Determination of the activated proto-oncogene (Ki-ras) in feces. A new laboratory analysis for early diagnosis of colorectal cancer].Tidsskr Nor Laegeforen. 1995 Oct 30;115(26):3266-70. Tidsskr Nor Laegeforen. 1995. PMID: 7482456 Review. Norwegian.
-
Identification of colon cancer patients by molecular diagnosis.Dig Dis. 2003;21(4):315-9. doi: 10.1159/000075354. Dig Dis. 2003. PMID: 14752221 Review.
Cited by
-
Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord.Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9704-9. doi: 10.1073/pnas.1511694112. Epub 2015 Jul 20. Proc Natl Acad Sci U S A. 2015. PMID: 26195750 Free PMC article.
-
Tumor DNA as a Cancer Biomarker through the Lens of Colorectal Neoplasia.Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2441-2453. doi: 10.1158/1055-9965.EPI-20-0549. Epub 2020 Oct 8. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 33033144 Free PMC article.
-
KRAS and BRAF mutation analysis in colorectal adenocarcinoma specimens with a low percentage of tumor cells.Mol Diagn Ther. 2013 Jun;17(3):193-203. doi: 10.1007/s40291-013-0025-8. Mol Diagn Ther. 2013. PMID: 23606169 Free PMC article.
-
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.Gut. 2003 Jan;52(1):101-8. doi: 10.1136/gut.52.1.101. Gut. 2003. PMID: 12477769 Free PMC article.
-
A Wipe-Based Stool Collection and Preservation Kit for Microbiome Community Profiling.Front Immunol. 2022 May 30;13:889702. doi: 10.3389/fimmu.2022.889702. eCollection 2022. Front Immunol. 2022. PMID: 35711426 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous